The enantiomerically pure cis-1,2-dihydrocatechols 2, which are generated by enzymatic dihydroxylation of the corresponding aromatic, engage in regio-and stereo-controlled Diels-Alder cycloaddition reactions to give a range of synthetically useful bicyclo[2.2.2]octenes. Certain examples of the latter type of compound have been used as starting materials in the synthesis of the sesquiterpenoids (-)-patchoulenone and (-)-hirsutene.
Dihydroxylation of monosubstituted benzenes (1) using a genetically engineered strain of E. coli that overexpresses the enzyme toluene dioxygenase (TDO) enables the large-scale production of enantiopure (>99.8 % ee) cis-1,2-dihydrocatechols of the general type 2 ( Fig. 1 ) [1] . Like others [2] , we [3] have been exploiting these densely functionalized and readily available metabolites as starting materials in the chemical synthesis of various classes of natural products. Such combined usage of chemical and enzymatic steps in the construction of target molecules is often referred to as chemoenzymatic synthesis. A concern often expressed about this approach is that since the enantiomeric enzyme is unlikely ever to be available then, correspondingly, the antipodal metabolite ent-2 would seem inaccessible. However, through a combination of chemical and enzymatic methods, it has been possible to address this matter. For example, by presenting the p-iodinated derivative, 3, of the original monosubstituted aromatic to TDO (Fig. 2 ) the sense of dihydroxylation is "reversed" and the cis-1,2-dihydrocatechol 4 becomes the predominant product [4] . Reductive removal of iodine, by either hydrogenolytic or elec-* Pure Appl. Chem. 75, 141-419 (2003) . An issue of reviews and research papers based on lectures presented at the 23 rd IUPAC International Symposium on the Chemistry of Natural Products, Florence, Italy, 28 July-2 August 2002 on the theme of natural products. ‡ Corresponding author: E-mail: mgb@rsc.anu.edu.au trochemical means, followed by an "enzymatic clean-up," to remove small quantities of compound 2, then delivers 5 (≡ ent-2) in essentially enantiomerically pure form.
Perhaps an even more attractive means for achieving enantiodivergence would be to start with a monochiral form of the cis-1,2-dihydrocatechol and convert this into either enantiomeric form of derivatives that would be useful building blocks for chemical synthesis. We have recently developed two Diels-Alder-based methods for achieving such outcomes, and these are shown in Figs. 3 and 4. In the first (Fig. 3) , the high-pressure (19 kbar) promoted reaction of the so-called toluene diol 2 (R = CH 3 ) with lactone 6 affords, via an endo-transition state and operation of the ortho-rule, bicyclo[2.2.2]octene 7 (56 %) as the major product of reaction [5] . The selective formation of this "syn-adduct" via addition of the dienophile to the more hindered (α) face of the diene seems counterintuitive, but has precedents [6] and may be rationalized on the basis that there is a stabilizing interaction between the π-bond of 6 and the O-H bonds of 2 (R = CH 3 ) [7] . The use of high pressure is essential because the reaction cannot be effected at elevated temperatures and/or in the presence of Lewis acid catalysts owing to the ready dehydration and accompanying aromatization of 2. If the acetonide derivative, 8, of 2 (R = CH 3 ) is subjected to the same reaction with dienophile 6 then, owing to the steric demand of the acetal moiety, the exclusive product of reaction is the β-face addition product or "anti-adduct" 9 [5] . The pseudoenantiomeric relationship between compounds 7 and 9 is readily discerned if one imagines hydrolysis of the latter to the corresponding diol 10, then oxidation of this and stereoisomer 9 to the respective (and mirror image) diketones, 11 and ent-11. In another example (Fig. 4) of an enantiodivergent route to bicyclo[2.2.2]octanes, the iodo-diol (2, R = I) is converted into the corresponding bis-crotonate 12 which, upon heating, engages in the two possible and competing intramolecular Diels-Alder reactions to afford a ca. 3:5 mixture of adducts 13 and 14 [8] . Each of these products can be readily purified by a combination of fractional crystallization and chromatographic techniques. The pseudo-enantiomeric rela- The reaction sequence leading from the C7 synthon 2 (R = CH 3 ) to the medicinally interesting cyperene-type sesquiterpene 16 is shown in Fig. 5 and begins with formation of the crystalline acetal 18 (53 %). A thermally promoted and diastereofacially selective Diels-Alder reaction of the latter compound with Corey's ketene-equivalent followed by base-promoted hydrolysis of the resulting epimeric mixture of α-chloronitriles gave bicyclo[2.2.2]octenone 19 in 86 % yield. gem-Dimethylation of the last compound afforded ketone 20 (89 %), which was hydrogenated to give the saturated equivalent 21 (100 %). Wittig olefination of compound 21 could not be achieved under conventional conditions because of the hindered nature of the carbonyl group, but use of high pressure allowed the target olefin 22 to be obtained in 86 % yield. Straightforward manipulation of the PMB acetal within substrate 22 then led, over four steps, to ketone 23 (81 % from 22), which was reacted with isopropenyl lithium to give, in a completely diastereoselective manner, the 1,5-dienol 24. This last compound engaged in an anionic oxy-Cope rearrangement on exposure to sodium hydride to give, after work-up, the bicyclo[5.3.1]octenone 25 in 76 % yield (from 23). The X-ray crystal structure of the latter compound reveals that the molecule adopts a distinctly U-shaped conformation, which brings the carbonyl and olefinic moieties into such close contact that samarium iodide-mediated one-electron reduction of this compound creates a ketyl radical anion that cyclizes onto the adjacent olefin. When thiophenol is used as a hydrogen atom source to "quench" the ensuing 3°-radical, then serviceable yields (74 %) of the compound 26, which incorporates the cyperene framework, can be obtained. Hydrogenolytic cleavage of the benzyl group within this product revealed a diol, the 2°-hydroxyl of which was oxidized to give acyloin 27 (65 % over two steps). Thionyl chloride/pyridine-mediated dehydration of compound 27 then gave (-)-patchoulenone 16 (72 %), the derived spectral data for which matched, in all respects, those reported cally pure material has been disclosed in over 20 years of activity in the area. Figure 6 delineates a synthesis of (-)-hirsutene (17) from toluene diol 2 (R = CH 3 ), and because the enantiomeric form of this starting material is also known (see Fig. 2 ) the work described constitutes a formal total synthesis of the natural material as well. In keeping with earlier observations, the high-pressure-promoted Diels-Alder reaction of diol 2 (R = CH 3 ) with cyclopentenone (28) afforded the α-face or "syn-addition" product 29 (70 %) as the major product of reaction. gem-Dimethylation of the acetonide derivative then gave compound 30 (98 %), and the now superfluous carbonyl unit was deleted by a stepwise reduction process involving a Barton-McCombie deoxygenation in the final step. The acetonide group associated with product 31 (75 %) was cleaved with aqueous acid, and the hydroxyl moiety remote from the bridgehead methyl group in the ensuing diol was selectively oxidized using the sterically demanding oxoammonium salt derived from 4-acetamidoTEMPO. The remaining hydroxyl group was then protected as the MEM-ether to give compound 32 (55 % from 31). In a pivotal step of the reaction sequence, and following on from concepts originally enunciated by Demuth and Schaffner [11] and recently exploited by Singh et al. [10] in his synthesis of (±)-17, bicyclo[2.2.2]octenone 32 was subject to a photochemically promoted oxa-di-π-methane rearrangement reaction thereby affording the cyclopropa-fused triquinane 33 (66 %). The structure of this photoproduct follows from NMR spectroscopic data and was confirmed by single-crystal X-ray analysis. Elaboration of compound 33 to the final target involved reductive cleavage of the cyclopropane ring, deletion of the carbonyl group using the same methods as employed earlier, then hydrolytic cleavage of the MEM-ether to give alcohol 34 (36 % over four steps). Completion of the synthesis required oxidation of the last compound to the corresponding ketone, then Wittig methylenation to give (-)-hirsutene (17) (98 % at 33 % conversion), the specific rotation for which was similar in magnitude (but opposite sign) to that reported by Hua et al. [12] for the natural product. While conceptually straightforward, these last few steps proved especially demanding from a practical viewpoint because of the exceptionally high vapor pressure of the final product, the precursor ketone, and the alcohol 34. While investigating the photochemical conversion 32 → 33, we noted formation of small amounts (5 %) of the isomeric cyclobutanone 35, which presumably arises via "leakage" through a singlet reaction pathway. Indeed, direct irradiation of ketone 32 with light from a medium-pressure mercury lamp afforded compound 35 in 66 % yield, and this was accompanied by ca. 5 % of the photodecarbonylation product 36. Significantly, these "new" photoproducts bear a strong structural resemblance to the protoilludane and marasmane sesquiterpenoids such as tsugicoline A (37) [13] and isovelleral (38) [14] , respectively. Of course, as synthesis chemists it is very tempting to try and effect the conversion 32 → 37 by chemical means because of the intriguing biological properties of the latter. Clearly, implementation of this idea requires, inter alia, the devising of a method for incorporation of a hydroxymethyl group. Even better, therefore, might be to try and develop procedures for the whole-cell biotransformation of m-methylbenzylalcohol (or an equivalent) into the corresponding cis-1,2-dihydrocatechol such that the 15 th carbon of target sesquiterpene 37 is in place from the beginning of the chemical parts of the synthesis. These sorts of considerations highlight another possible area for development in the field of chemoenzymatic synthesis. Rather than simply "making do" with already available cis-1,2-dihydrocatechols as starting materials, can we generate new sets of metabolites that are "customized" for a particular synthetic task? While that is easier said than done, especially in cases where TDO cannot effectively dihydroxylate the relevant substrate, it may be possible, through application of gene shuffling and directed evolution techniques [15] , to generate mutant enzymes/organisms capable of performing the required task. So, it would be nice to think that one day synthesis chemists might have access to a vast range of mutant cell lines that enable the selective biotransformation of any one of the large number of abundant aromatic feed stocks into any synthetically desirable dihydrocatechol or related metabolite. Such possibilities, when considered in conjunction with the abovementioned "tricks" (Figs. 3 and 4) available for enantiomeric switching, suggest a promising future for the chemoenzymatic synthesis of terpenoids and other natural products from aromatic metabolites.
